Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net income	$ 1,819	$ 14,975
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation	4,057	4,032
Amortization of deferred debt issuance costs	1,506	880
Amortization	13,877	12,799
Stock-based compensation	5,726	4,463
Deferred income taxes	(1,140)	177
Non-cash adjustment to fair value of contingent consideration liability	4,436	0
Increase (decrease) in cash flows from changes in assets and liabilities:
Accounts receivable	(20,666)	(163)
Inventories	(3,016)	(21,857)
Accounts payable	2,699	9,205
Accrued compensation and benefits	(5,722)	(14,966)
Other assets	(11,372)	(6,129)
Other liabilities	3,949	(3,088)
Net cash (used in) provided by operating activities	(3,847)	328
Cash flows from investing activities:
Purchases of property, plant and equipment	(4,254)	(3,687)
Net cash used in investing activities	(4,254)	(3,687)
Cash flows from financing activities:
Payments on term loan	0	(2,981)
Payments on revolving line of credit	(164,000)	(99,000)
Proceeds from revolving line of credit	173,000	110,000
Payments related to contingent consideration	0	(798)
Dividends paid on common stock	(6,098)	(5,874)
Other, net	2,448	6,142
Net cash provided by financing activities	5,350	7,489
Effect of exchange rate changes on cash and cash equivalents	303	(113)
Net (decrease) increase in cash and cash equivalents	(2,448)	4,017
Cash and cash equivalents at beginning of period	28,942	20,847
Cash and cash equivalents at end of period	26,494	24,864
Non-cash investing and financing activities:
Dividends payable	$ 6,113	$ 5,899